{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:17:47Z","timestamp":1781014667785,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1379,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pfizer\/Tufts Medical Center through the Institute of Clinical Research and Health Policy Studies"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbmt.2010.10.025","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T04:56:50Z","timestamp":1288069010000},"page":"1012-1017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"17","author":[{"given":"Shih Hann","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Martel-Laferri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie-Claude","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Snydman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Laverdi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"B\u00e9liveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Logvinenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvy","family":"Lachance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.10.025_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bbmt.2010.10.025_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation","volume":"152","author":"Locksley","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib3","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications","volume":"13","author":"Han","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bmt.2009.258","article-title":"Viral disease prevention after hematopoietic cell transplantation","volume":"44","author":"Zaia","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation: a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.10.025_bib8","first-page":"185","article-title":"Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro","volume":"1","author":"Ljungman","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib9","first-page":"99","article-title":"Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"85","author":"Perren","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2010.10.025_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1703819","article-title":"Increasing use of reduced-intensity conditioning transplants: report of the 2001 EBMT activity survey","volume":"30","author":"Gratwohl","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bmt.2009.7","article-title":"The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies","volume":"43","author":"Gratwohl","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/10428190500264496","article-title":"Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation","volume":"46","author":"Schulenburg","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2010.10.025_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/bmt.2008.313","article-title":"Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma","volume":"43","author":"Bachanova","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-3062.2004.00075.x","article-title":"Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation","volume":"6","author":"Meijer","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bbmt.2007.06.013","article-title":"High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation","volume":"13","author":"Labbe","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2009.04.004","article-title":"Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality","volume":"15","author":"Sabry","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2004.04945.x","article-title":"Chronic graft-versus-host disease","volume":"125","author":"Higman","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.10.025_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib19","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-100-6-823","article-title":"Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation","volume":"100","author":"Wade","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2010.10.025_bib21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/315146","article-title":"Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Gay Cohort Study; Multicenter Hemophilia Cohort Study","volume":"180","author":"Engels","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinids\/21.2.370","article-title":"Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus","volume":"21","author":"Glesby","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00002030-199510000-00006","article-title":"Herpes zoster, immunological deterioration and disease progression in HIV-1 infection","volume":"9","author":"Veenstra","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2010.10.025_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jama.2009.150","article-title":"Herpes zoster in the age of focused immunosuppressive therapy","volume":"301","author":"Whitley","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2010.10.025_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1399-3062.2003.00027.x","article-title":"Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"5","author":"Busca","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1705255","article-title":"Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen","volume":"37","author":"Frere","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.10.025_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-3062.2007.00247.x","article-title":"Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders","volume":"10","author":"Kim","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","article-title":"Mini-allografts: ongoing trials in humans","volume":"25","author":"Carella","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2010.10.025_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2010.10.025_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbmt.2006.10.015","article-title":"Reduced-intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives","volume":"13","author":"Sandmaier","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2010.10.025_bib34","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.10.025_bib35","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib36","article-title":"A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT","author":"Klein","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.10.025_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N\u00a0Engl J Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110004751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110004751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:38:38Z","timestamp":1761057518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110004751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1083879110004751"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.10.025","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}